Blood cancer therapy with synthetic receptors and CRISPR technology

2025/01/08 by Haiying Zhang, Mingxin Zhong, Jingdong Zhang +1 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Biology #CAR-T cell therapy research #CRISPR #CRISPR and Genetic Engineering #Cancer #Cancer research #Computational biology #Gene #Genetics #Internal medicine #Medicine #Receptor #Virus-based gene therapy research

paper · doi:10.1016/j.leukres.2025.107646

openalex publication_date 2025/01/08 · crossref created 2025/01/08 · crossref issued 2025/03/01 · crossref published 2025/03/01 · crossref published-print 2025/03/01 · openalex created_date 2025/10/10 · crossref deposited 2026/05/12 · crossref indexed 2026/05/16 · openalex updated_date 2026/08/06

Citations

• Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
• Neoantigens in cancer immunotherapy
• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Discussions

• Review: Blood cancer therapy with synthetic receptors and CRISPR technology doi.org/10.1016/j.le... [bsky, 0 points, 0 comments]